Form Approved
OMB Control No. 0920-1071
Exp. Date: 06/30/2018
Attachment 2: ME/CFS: Healthcare Provider Perspective Interview
INTRODUCTION
Voluntary Consent to Participate in an Individual Interview
Discussing Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Hello/Good morning/Good afternoon…. I want to welcome you to the individual interview conference call.
My name is Dana Brimmer, and I am calling from the Synergy America Inc., a contractor for the Centers for Disease Control and Prevention (CDC). You are scheduled for an interview regarding Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Is this still a good time to do the interview?
If No – May I reschedule the interview at a time that is convenient for you?
If Yes – Before we begin the interview, I need to review a few details about the study with you.
PUrPose
This interview is part of a series of interviews called ME/CFS: Healthcare Provider Perspective Interview. CDC ME/CFS program wants to hear from healthcare providers about the ME/CFS diagnosis process, managing ME/CFS patients, patient-centered outcomes in office visits, and preferred sources of educational materials. The information will help assess current materials, revising materials, and guide education of healthcare professionals.
The Centers for Disease Control and Prevention (CDC) is sponsoring this interview; Synergy America Inc, a company headquartered in Duluth, Georgia is the CDC’s contractor to conduct this interview.
You have been asked to participate in this interview because you are a healthcare provider that sees patients. We will be conducting up to 30 telephone interviews with other healthcare providers.
Our interview today will take about 30 minutes.
Confidentiality
CDC will treat data in a secure manner and will not disclose, unless otherwise compelled by law. The interview will be recorded so that we have accurate documentation of your responses. The recording of your interview will be labeled with a study code, not your name. The recording will be transcribed and your name will not be linked to the responses you provide in the interview. The information you provide during the interview will be used in reports to the government in summary form only; your name will not be included in the report. Synergy American Inc. will continue to keep the recording of your interview in secure storage until five years from this interview (Month Year). At that time, the recording will be destroyed.
Voluntary Participation
Please understand that your participation in this interview is voluntary. You may stop at any time. You do not need to give a reason. If you decide not to participate, you may still take part in other CDC programs and research, now or in the future, without forfeiting benefits. You may also withdraw from this study without penalty after starting your interview. Even if you agree to participate, you are not required to answer all the questions you are asked.
Compensation
You will receive $20 for completing and participating in the interview.
Questions
Do you have any questions?
You may phone Study Co-Director Dana Brimmer, Ph.D., a contractor with Synergy America Inc., at (xxx) xxx-xxxx to have your questions answered. If you have any questions about your rights as an interview participant, you may call the CDC Human Research Protection Office at (800) 584-8814. Please mention that you are calling in reference to CDC protocol #7057. You may also call the CDC Principal Investigator, Sally Lin, Ph.D., at (404) 639-1646. Calls to Dr. Brimmer or Dr. Lin may be toll calls.
Given the information that I have just reviewed with you, do you still wish to participate in this study/interview?
If No, _______[Interviewer’s initials]. Thank the participant for his/her time.
If Yes, _____[Interviewer’s initials]. Great. Let’s get started. I want to let you know that there are no right or wrong answers for this interview. We’d like you to be honest in your responses.
ME/CFS
1. What is the first thing that comes to your mind when you think of patients with ME/CFS?
Probe: why those items came to mind if it’s not obvious
Challenging
Lack of time
Difficult patients
Frustrating
2. Do you think your opinions are typical?
Probe: Do your colleagues have different opinions?
3. What information would you gather in order to diagnose a patient with ME/CFS?
Probe:
Medical history
Assess symptoms
Diagnostic tests
Refer to specialists
4. Once a ME/CFS diagnosis is made, what additional information might you seek to guide treatment?
Probe:
Diagnostic tools (or guideline)
CME courses
Fact sheets
5. What can be done to improve patient outcomes for patients with ME/CFS?
Probe:
Strategies for treatment/management
Strategies for communication
6. Where would you go to find out more information about ME/CFS?
Probe:
Workplace
CME
Medical library
CDC website
Internet (examples?)
ME/CFS Patient Scenarios (5 minutes)
Now I am going to share two scenarios that ME/CFS patients could experience.
A new patient says this to you:
“I’ve been to so many doctors who don’t care if I come back or not, because I took up too much of their time. And after so many visits, I’m still as sick as I was at the first time I walked into the door. And when they don’t see results, they are pretty much done But I would like a doctor to just be compassionate and really say “what can I do for you?”
Questions:
7. What is the first thing that comes in mind when you hear a patient say something like this?
8. What would you do for this patient?
You over hear two people talking in a coffee shop:
“I want a doctor who’s willing to not blame the patient for a disease that seems very difficult to treat, and maybe impossible to cure. . . I find that for patients like me, we don’t necessarily mind too much if the doctor can’t help us. But we mind very much if the doctor blames us, or if a doctor dismisses us. But I find if the doctor will be willing to hang in there with the patient that means everything.”
9. What are the barriers/facilitators to hanging in there with a patient?
Patient-Centered Outcomes (15 minutes)
Questions:
10. What are your goals when managing patients with chronic illnesses more broadly, such as . . . . . . . . . . ?
Probe:
Quality of life
Symptom management
Refer to a specialist
Other
11. Would you manage a ME/CFS patient the same way?
Probe: Why or why not?
12. What do you think when you hear the concept “patient-centered outcomes”?
Probe: Read definition after hearing answers
Quality of life
Care through patient’s eyes
Benefits/harms of medical recommendations
Patient preferences/goals
Communication
13. What is the best way for healthcare providers to incorporate patient centered outcomes into office visits?
14. What resources do healthcare providers need to incorporate “patient- centered outcomes” into clinical practice?
15. People with ME/CFS may experience the following symptoms:
fatigue
post-exertional malaise
limited function
sleep problems
cognitive impairment
pain
16. What would be helpful to healthcare providers in managing patients with these symptoms?
17. What would prevent you from managing a patient’s ME/CFS?
Probe:
Time commitment
Too expensive
Too labor intensive
Complaints from staff
Hearsay from a colleague
Others
Conclusion
That’s the end of the formal questions I have for you. Do you have any questions for me? Thank you for your time and participation today.
Public reporting burden of this collection of information is estimated to take 40 per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA 0920-1071.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | Final Focus Group Guide (11/22/04) |
Author | Dana Jones Benet |
File Modified | 0000-00-00 |
File Created | 2021-01-21 |